Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Vinnie YT Liu"'
Autor:
Daniel Eidelberg Spratt, Vinnie YT Liu, Rikiya Yamashita, Emmalyn Chen, Sandy DeVries, Ashley Ross, Angela Jia, Todd Matthew Morgan, Seth A. Rosenthal, Howard M. Sandler, Osama Mohamad, Andre Esteva, Jedidiah Mercer Monson, Steven J. Chmura, John H Carson, Alan C Hartford, Albert J Chang, Stephanie L. Pugh, Phuoc T. Tran, Felix Y Feng
Publikováno v:
Journal of Clinical Oncology. 41:299-299
299 Background: Recently, an MMAI prognostic biomarker, ArteraAI Prostate, was trained and validated in localized prostate cancer to more accurately risk stratify patients for multiple endpoints compared to NCCN risk groups (Esteva et al., 2022). Pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1eb7e0805a8c68eed76df8e6a33032cd
https://doi.org/10.1200/jco.2023.41.6_suppl.299
https://doi.org/10.1200/jco.2023.41.6_suppl.299
Autor:
Nicholas George Zaorsky, James Alexander Proudfoot, Randy Vince, Yang Liu, Vinnie YT Liu, Raed Zuhour, Angela Y Jia, Yilun Sun, Jim C. Hu, Jonathan Evan Shoag, Edward M. Schaeffer, Elai Davicioni, Valentina I. Petkov, Daniel Eidelberg Spratt
Publikováno v:
Journal of Clinical Oncology. 40:e17006-e17006
e17006 Background: In 2021, national data between the Decipher 22-gene prognostic gene expression classifier (GC) for men with prostate cancer and the Surveillance, Epidemiology, and End Results (SEER) cancer registries were linked. The purpose of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a7c2fff175d471c732e80834f15d25b
https://doi.org/10.1200/jco.2022.40.16_suppl.e17006
https://doi.org/10.1200/jco.2022.40.16_suppl.e17006